Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.

Cheah AL, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

BMC Infect Dis. 2014 Jun 28;14:353. doi: 10.1186/1471-2334-14-353.

2.

Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.

Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D.

Clin Microbiol Infect. 2012 Apr;18(4):388-94. doi: 10.1111/j.1469-0691.2011.03591.x. Epub 2011 Aug 16.

3.

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.

Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

Clin Microbiol Infect. 2013 Apr;19(4):E181-9. doi: 10.1111/1469-0691.12132. Epub 2013 Feb 7.

4.

Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.

Vydra J, Shanley RM, George I, Ustun C, Smith AR, Weisdorf DJ, Young JA.

Clin Infect Dis. 2012 Sep;55(6):764-70. doi: 10.1093/cid/cis550. Epub 2012 Jun 12.

5.

Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay.

Cheah AL, Spelman T, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

Epidemiol Infect. 2014 Dec;142(12):2667-71. doi: 10.1017/S095026881400020X.

PMID:
25372228
6.

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, Ballow CH.

Diagn Microbiol Infect Dis. 2000 Mar;36(3):145-58.

PMID:
10729656
7.

Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.

McCracken M, Wong A, Mitchell R, Gravel D, Conly J, Embil J, Johnston L, Matlow A, Ormiston D, Simor AE, Smith S, Du T, Hizon R, Mulvey MR; Canadian Nosocomial Infection Surveillance Program.

J Antimicrob Chemother. 2013 Jul;68(7):1505-9. doi: 10.1093/jac/dkt054. Epub 2013 Mar 22.

8.

Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.

Papadimitriou-Olivgeris M, Drougka E, Fligou F, Kolonitsiou F, Liakopoulos A, Dodou V, Anastassiou ED, Petinaki E, Marangos M, Filos KS, Spiliopoulou I.

Infection. 2014 Dec;42(6):1013-22. doi: 10.1007/s15010-014-0678-1. Epub 2014 Aug 21.

PMID:
25143193
9.

Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.

Lu CL, Chuang YC, Chang HC, Chen YC, Wang JT, Chang SC.

J Antimicrob Chemother. 2012 Sep;67(9):2243-9. doi: 10.1093/jac/dks181. Epub 2012 May 22.

10.

[Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates].

Coşkun FA, Mumcuoğlu I, Aksu N, Karahan ZC, Us E, Tekeli FA, Baran I, Kanyılmaz D, Kurşun S.

Mikrobiyol Bul. 2012 Apr;46(2):276-82. Turkish.

PMID:
22639316
11.

Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities.

Yameen MA, Iram S, Mannan A, Khan SA, Akhtar N.

BMC Infect Dis. 2013 Mar 27;13:156. doi: 10.1186/1471-2334-13-156.

12.

Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.

Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA.

Am J Infect Control. 2006 Sep;34(7):447-51.

PMID:
16945692
13.

vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.

Suppola JP, Kolho E, Salmenlinna S, Tarkka E, Vuopio-Varkila J, Vaara M.

J Clin Microbiol. 1999 Dec;37(12):3934-9.

14.

Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.

da Silva NS, Muniz VD, Estofolete CF, Furtado GH, Rubio FG.

Am J Infect Control. 2014 Apr;42(4):389-92. doi: 10.1016/j.ajic.2013.11.010.

PMID:
24679566
15.
16.

Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.

Miyazaki S, Fujikawa T, Kobayashi I, Matsumoto T, Tateda K, Yamaguchi K.

J Med Microbiol. 2001 Aug;50(8):695-701.

PMID:
11478673
17.

Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.

Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD.

Clin Infect Dis. 1998 May;26(5):1127-33.

18.

Prevalence and detection of mixed-population enterococcal bacteremia.

Cárdenas AM, Andreacchio KA, Edelstein PH.

J Clin Microbiol. 2014 Jul;52(7):2604-8. doi: 10.1128/JCM.00802-14. Epub 2014 May 14.

19.

Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.

Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E, Pettit NN.

Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4.

PMID:
23911080
20.
Items per page

Supplemental Content

Write to the Help Desk